Psychedelics Market Could Reach $12B By 2029, Says New Report

A new analysis of the global market for psychedelics performed by Brandessence Market Research shows an expected growth from 2022’s $4.87 billion to an annual valuation of nearly $12 billion before 2030.

According to the report, the market for psychedelic drugs used for therapeutic purposes -including LSD, ketamine, MDMA, psilocybin and ayahuasca- would expand at a Compound Annual Growth Rate (CAGR) of 13.49%. 

The analysis highlights what it considers to be the world’s key players in the industry, including a couple of businesses that have been specifically created for the purpose of developing psychedelics -see COMPASS Pathways CMPS and PharmaTher Holdings PHRRF, among others.

The document’s authors state that these companies “are trying to attain a firm grip over this intensely competitive market” by formulating “extensive business-centric strategies to amplify their global footprint” such as M&As, R&D investment, product launches, partnerships and collaborations.

See also: Psyched: Psychedelics In Davos, Prince Harry In The 90s, Cathie Wood's Latest Moves And More

The report also identifies factors that will likely contribute to the market’s growth all the way to 2030. One of them would be the higher awareness of psychedelics’ mental health benefits and the “rising prevalence” of depression and other mental health disorders on a global scale. 

According to the report’s authors, “changes in lifestyle and the desire for a higher and better quality of life” would also contribute towards this market growth. 

This point could be related to the fact that the coronavirus pandemic actually held a positive impact on the psychedelic drugs market.

“People were confined to their homes and had no scope for social interaction. This impacted the mental health of many. In fact, during the pandemic era, the world witnessed a steep rise in the number of suicides triggered by mental health disorders. This escalated the demand for effective drugs to treat such disorders.” 

Photo: Benzinga edit with photo by chrissmith12 and Bru-nO on Pixabay.

Posted In: CannabisNewsPsychedelicsSmall CapMarketsanalyst reportGlobal Psychedelics Therapeutic MarketPsychedelic-Assisted Therapies
Benzinga simplifies the market for smarter investing

Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.

Join Now: Free!

The Benzinga Cannabis Capital Conference is coming to Florida

The Benzinga Cannabis Capital Conference is returning to Florida, in a new venue in Hollywood, on April 16 and 17, 2024. The two-day event at The Diplomat Beach Resort will be a chance for entrepreneurs, both large and small, to network, learn and grow. Renowned for its trendsetting abilities and influence on the future of cannabis, mark your calendars – this conference is the go-to event of the year for the cannabis world.

Get your tickets now on bzcannabis.com – Prices will increase very soon!


Loading...